Nano Ruffles in Brain Matter
Researchers decipher the role of nanostructures around brain cells in central nervous system function
Nils Blumenthal und Prasad Shastri
The researchers found that there is a restricted regime of roughness at the nanoscale that is beneficial to neurons. If the magnitude of roughness exceeds or is below this regime, neurons experience detrimental changes to their function. By analyzing human brain tissue from patients who suffered from Alzheimer’s disease, Shastri’s team has found a crucial link between regions in the brain that have amyloid-beta plaque accumulation – which are responsible for neuron death – and unfavorable changes to the nanotopography in the tissue surrounding these neurons, that is the features of its surface.
Shastri and his co-workers have found that astrocytes provide a nanoscale physical environment that neurons need to function well. “Our discovery shows for the first time that stretch-activated ion channels may have a role in central nervous system function and disease. Hence, our findings offer new pharmacological targets”, says Blumenthal. Using synthetic substrates of precise roughness, they found out that stretch-sensitive molecules, including the so-called Piezo-1 ion channel in murine brain cells, direct the interaction between nanotopography, astrocytes and neurons. Former research has shown that the expression of MIB-1, a human analog of Piezo-1, is altered in human Alzheimer’s patients.
Prof. Prasad Shastri conducts his research at the Institute for Macromolecular Chemistry and the Excellence Cluster BIOSS Centre for Biological Signalling Studies of the University of Freiburg. Graduate student Nils Blumenthal is funded by BIOSS. Prof. Bernd Heimrich is at the Institute of Anatomy and Cell Biology of the University of Freiburg and Prof. Ola Hermanson is from the Karolinska Institute in Stockholm/Sweden.
Original publication
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.